NCT05430477View on ClinicalTrials.gov

Characterizing In Vivo Oral Lesion Impedances

CompletedOBSERVATIONAL
Enrollment

114

Participants

Timeline

Start Date

August 29, 2022

Primary Completion Date

June 30, 2025

Study Completion Date

August 20, 2025

Conditions
Oral Lesion
Interventions
DEVICE

Electrical impedance imaging using Non-Significant Risk device (EII probe)

novel small field-of-view Non-Significant Risk device (EII probe)

Trial Locations (1)

03756

Dartmouth-Hitchcock Medical Center, Lebanon

All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

collaborator

National Institute of Dental and Craniofacial Research (NIDCR)

NIH

collaborator

Dartmouth College

OTHER

lead

Ryan J. Halter

OTHER